In conclusion, the current study confirms that TM6SF2 is associated with histologically defined NAFLD, and is the first demonstration that this gene serves as a powerful modifier of hepatic fibrogenesis. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.